- Record: found
- Abstract: not found
- Book: not found
Resolution of the Federal Joint Committee on an amendment of the pharmaceuticals directive: Annex XII – Benefit assessment of medicinal products with new active ingredients according to section 35a SGB V Erenumab (reassessment due to new scientific knowledge (prophylaxis of migraine))
2021
Read this book at
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.